|
|
FDADocs 5/12/2008 | 0 (0) | 18 | 0 | 0 | English
Drug Development for Resistant Pathogens-PhRMA Antibiotics Working GroupFrancis P. Tally MD Cubist Pharmaceuticals, Inc. November 19, 2002Antimicrobial Resistance in Nosoc... ... more>>
FDADocs 5/12/2008 | 0 (0) | 41 | 0 | 0 | English
FDA Experience and Perspective on Non-Inferiority TrialsRobert J. Temple, M.D. Associate Director for Medical Policy Center for Drug Evaluation and Research U.S. Food and Drug AdministrationFDA ... more>>
FDADocs 5/12/2008 | 0 (0) | 16 | 0 | 0 | English
Issues??and??Controversies??in??DILI?? Session??I:????FDA??Concept??Paper???????Premarketing...?? UNC?? GSK?? FDA?? FDA?? PhRMA??Session??1.1?? Drafting??of??Concept??Paper:????Premarketing ... more>>
FDADocs 5/12/2008 | 0 (0) | 20 | 0 | 0 | English
://www.fda.gov/cber/guidelines.htm. For questions on the content of this guidance, contact the ... more>>
FDADocs 5/12/2008 | 0 (0) | 15 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 16 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 16 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 16 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 17 | 0 | 0 | English
FDADocs 5/12/2008 | 0 (0) | 19 | 0 | 0 | English
CALL FOR ABSTRACTS Poster Session on Genomics and Proteomics10TH Annual FDA Science ForumFDA Science: The Critical Path from Concept to ConsumerMay 18-19, 2004, Washington Convention Center ... more>>
FDADocs 5/12/2008 | 0 (0) | 27 | 1 | 0 | English
SPL DemonstrationJune 4, 2004Who is FCG?Who is FCG?A leading provider of consulting, technology, applied research and outsourcing services to the life sciences and he... ... more>>
FDADocs 5/12/2008 | 0 (0) | 13 | 0 | 0 | English
FDA Flawed Gate keepingTestimony Vera Sharav President Alliance for Human Research Protection... intervention.???FDA Prozac Safety Review, 1990???The data showed higher percentages of suicidality ... more>>
FDADocs 5/12/2008 | 0 (0) | 23 | 0 | 0 | English
FDA Public Hearing Regarding Medication Guide Program ReformJune 12, 2007Steve Heidenthal, R.Ph. CVS Caremark Corporation-0-CVS Caremark BackgroundIntegrated pharmacy services ... more>>
FDADocs 5/12/2008 | 0 (0) | 13 | 0 | 0 | English
FDA???s NPRM on Removing the Essential-use Designations of 7 Marketed ???Moieties???Robert J... ozone depletion ??? Introduction to relevant decisions of the Montreal Protocol, U.S. Laws, and FDA ... more>>
FDADocs 5/12/2008 | 0 (0) | 19 | 0 | 0 | English
FDA Review of Rx to OTC FDA Review of Rx to OTC Consumer Studies involving Consumer Studies... Nonprescription Clinical Evaluation, FDA Division of Nonprescription Clinical Evaluation, FDAAdolescent ... more>>
| | | |
| results / page 15/25/50 |
Page: 2 of 33
|
2...
|
|